| 17beta-estradiol | increases expression | ISO | RGD:1343291 | 6480464 | Estradiol results in increased expression of RGS16 mRNA | CTD | PMID:19153601 |
| 17beta-estradiol | affects expression | ISO | RGD:11238 | 6480464 | Estradiol affects the expression of RGS16 mRNA | CTD | PMID:15598610 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:11238 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RGS16 mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:11238 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGS16 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGS16 mRNA | CTD | PMID:22298810 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:11238 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of RGS16 mRNA] | CTD | PMID:19467301 |
| 5-fluorouracil | affects expression | ISO | RGD:1343291 | 6480464 | Fluorouracil affects the expression of RGS16 mRNA | CTD | PMID:15205334 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1343291 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RGS16 mRNA | CTD | PMID:22079614 |
| aflatoxin B1 | decreases expression | ISO | RGD:11238 | 6480464 | Aflatoxin B1 results in decreased expression of RGS16 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | ISO | RGD:1343291 | 6480464 | Aflatoxin B1 results in increased expression of RGS16 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1343291 | 6480464 | Tretinoin results in decreased expression of RGS16 mRNA | CTD | PMID:16129123 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1343291 | 6480464 | Tretinoin results in decreased expression of RGS16 mRNA | CTD | PMID:16129123 more ... |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1343291 | 6480464 | Tretinoin results in decreased expression of RGS16 mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1343291 | 6480464 | Tretinoin results in decreased expression of RGS16 mRNA | CTD | PMID:15498508 more ... |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1343291 | 6480464 | Tretinoin results in decreased expression of RGS16 mRNA | CTD | PMID:21934132 PMID:16129123 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1343291 | 6480464 | Tretinoin results in increased expression of RGS16 mRNA | CTD | PMID:16012519 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:11238 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of RGS16 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:11238 | 6480464 | Benzo(a)pyrene results in decreased expression of RGS16 mRNA | CTD | PMID:19770486 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:11238 | 6480464 | Diethylhexyl Phthalate results in decreased expression of RGS16 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:11238 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of RGS16 mRNA] | CTD | PMID:19850644 |
| cadmium dichloride | affects methylation | EXP | | 6480464 | Cadmium Chloride affects the methylation of RGS16 promoter | CTD | PMID:22457795 |
| clofibrate | multiple interactions | ISO | RGD:11238 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RGS16 mRNA] | CTD | PMID:17585979 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RGS16 mRNA | CTD | PMID:17602206 |
| copper(2+) sulfate | increases expression | ISO | RGD:1343291 | 6480464 | Copper Sulfate results in increased expression of RGS16 mRNA | CTD | PMID:19549813 |
| curcumin | increases expression | ISO | RGD:1343291 | 6480464 | Curcumin results in increased expression of RGS16 mRNA | CTD | PMID:17198877 |
| cyclosporin A | increases expression | ISO | RGD:1343291 | 6480464 | Cyclosporine results in increased expression of RGS16 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1343291 | 6480464 | Cyclosporine results in decreased expression of RGS16 mRNA | CTD | PMID:22147139 |
| cyclosporin A | decreases expression | ISO | RGD:11238 | 6480464 | Cyclosporine results in decreased expression of RGS16 mRNA | CTD | PMID:19770486 |
| dibutyl phthalate | increases expression | ISO | RGD:11238 | 6480464 | Dibutyl Phthalate results in increased expression of RGS16 mRNA | CTD | PMID:21266533 |
| doxorubicin | affects expression | ISO | RGD:1343291 | 6480464 | Doxorubicin affects the expression of RGS16 mRNA | CTD | PMID:15205334 |
| formaldehyde | increases expression | ISO | RGD:1343291 | 6480464 | Formaldehyde results in increased expression of RGS16 mRNA | CTD | PMID:17938736 |
| fumonisin B1 | decreases expression | ISO | RGD:11238 | 6480464 | fumonisin B1 results in decreased expression of RGS16 mRNA | CTD | PMID:16221962 |
| genistein | decreases expression | ISO | RGD:1343291 | 6480464 | Genistein results in decreased expression of RGS16 mRNA | CTD | PMID:15256057 |
| hydrogen peroxide | affects expression | ISO | RGD:1343291 | 6480464 | Hydrogen Peroxide affects the expression of RGS16 mRNA | CTD | PMID:20044591 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of RGS16 mRNA | CTD | PMID:21396975 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGS16 mRNA | CTD | PMID:22129741 |
| kainic acid | decreases expression | ISO | RGD:11238 | 6480464 | Kainic Acid results in decreased expression of RGS16 mRNA | CTD | PMID:17997037 |
| leflunomide | decreases expression | ISO | RGD:11238 | 6480464 | leflunomide results in decreased expression of RGS16 mRNA | CTD | PMID:19751817 |
| melphalan | increases expression | ISO | RGD:1343291 | 6480464 | Melphalan results in increased expression of RGS16 mRNA | CTD | PMID:22363485 |
| menadione | affects expression | ISO | RGD:1343291 | 6480464 | Vitamin K 3 affects the expression of RGS16 mRNA | CTD | PMID:20044591 |
| N(6)-dimethylallyladenine | decreases expression | ISO | RGD:1343291 | 6480464 | N(6)-(delta(2)-isopentenyl)adenine results in decreased expression of RGS16 mRNA | CTD | PMID:16129123 |
| N(6)-dimethylallyladenine | increases expression | ISO | RGD:1343291 | 6480464 | N(6)-(delta(2)-isopentenyl)adenine results in increased expression of RGS16 mRNA | CTD | PMID:16129123 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGS16 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RGS16 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of RGS16 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of RGS16 mRNA | CTD | PMID:18164116 |
| naphthalene | increases expression | ISO | RGD:11238 | 6480464 | naphthalene results in increased expression of RGS16 mRNA | CTD | PMID:18978301 |
| nickel sulfate | increases expression | ISO | RGD:1343291 | 6480464 | nickel sulfate results in increased expression of RGS16 mRNA | CTD | PMID:16780908 |
| paracetamol | multiple interactions | ISO | RGD:11238 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of RGS16 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:1343291 | 6480464 | Acetaminophen results in increased expression of RGS16 mRNA | CTD | PMID:21420995 |
| paracetamol | decreases expression | ISO | RGD:11238 | 6480464 | Acetaminophen results in decreased expression of RGS16 mRNA | CTD | PMID:11264010 |
| phenobarbital | decreases expression | ISO | RGD:11238 | 6480464 | Phenobarbital results in decreased expression of RGS16 mRNA | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:1343291 | 6480464 | Phenobarbital affects the expression of RGS16 mRNA | CTD | PMID:19159669 |
| phenobarbital | increases expression | ISO | RGD:11238 | 6480464 | Phenobarbital results in increased expression of RGS16 mRNA | CTD | PMID:19270015 |
| phenobarbital | multiple interactions | ISO | RGD:11238 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of RGS16 mRNA] | CTD | PMID:19482888 |
| phosgene | affects expression | ISO | RGD:11238 | 6480464 | Phosgene affects the expression of RGS16 mRNA | CTD | PMID:16300373 |
| pirinixic acid | decreases expression | ISO | RGD:11238 | 6480464 | pirinixic acid results in decreased expression of RGS16 mRNA | CTD | PMID:20059764 PMID:16221962 |
| pirinixic acid | decreases expression | ISO | RGD:11238 | 6480464 | pirinixic acid results in decreased expression of RGS16 mRNA | CTD | PMID:16221962 PMID:20059764 |
| pirinixic acid | multiple interactions | ISO | RGD:11238 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of RGS16 mRNA] | CTD | PMID:20059764 |
| pirinixic acid | multiple interactions | ISO | RGD:11238 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of RGS16 mRNA] | CTD | PMID:16221962 |
| pirinixic acid | increases expression | ISO | RGD:11238 | 6480464 | pirinixic acid results in increased expression of RGS16 mRNA | CTD | PMID:18445702 |
| propiconazole | decreases expression | ISO | RGD:11238 | 6480464 | propiconazole results in decreased expression of RGS16 mRNA | CTD | PMID:21278054 |
| raloxifene | multiple interactions | ISO | RGD:1343291 | 6480464 | [Raloxifene co-treated with ESR1 protein] results in decreased expression of RGS16 mRNA | CTD | PMID:19059307 |
| silicon dioxide | increases expression | ISO | RGD:11238 | 6480464 | Silicon Dioxide results in increased expression of RGS16 mRNA | CTD | PMID:19073995 |
| succimer | multiple interactions | ISO | RGD:11238 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS16 mRNA | CTD | PMID:21641980 |
| tamibarotene | decreases expression | ISO | RGD:1343291 | 6480464 | Am 80 results in decreased expression of RGS16 mRNA; more ... | CTD | PMID:15498508 |
| tamoxifen | multiple interactions | ISO | RGD:1343291 | 6480464 | [Tamoxifen co-treated with ESR1 protein] results in decreased expression of RGS16 mRNA | CTD | PMID:19059307 |
| tamoxifen | affects expression | ISO | RGD:11238 | 6480464 | Tamoxifen affects the expression of RGS16 mRNA | CTD | PMID:20937368 |
| theophylline | increases expression | ISO | RGD:1343291 | 6480464 | Theophylline results in increased expression of RGS16 mRNA | CTD | PMID:16083514 |
| titanium dioxide | increases expression | ISO | RGD:11238 | 6480464 | titanium dioxide results in increased expression of RGS16 mRNA | CTD | PMID:21259345 |
| zinc atom | multiple interactions | ISO | RGD:1343291 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RGS16 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1343291 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RGS16 mRNA | CTD | PMID:18593933 |